The Global Antibiotics Market Size accounted for USD 42 Billion in 2021 and is estimated to garner a market size of USD 63 Billion by 2030 rising at a CAGR of 4.6% from 2022 to 2030. Antibiotics are medicines that help in fighting against bacterial infection in humans as well as animals. They kill the bacteria or prevent them from growing and multiplying in the host. Additionally, the antibiotics can be taken in different ways that include orally, topically, or intravenously according to the requirement of the person or the intensity of the infection. Advent of novel approaches for new antibiotics is a popular antibiotics market trend that is pushing the industry growth forward.
Antibiotics Market Report Key Highlights
Global Antibiotics Market Dynamics
Antibiotics Market Report Coverage
|Antibiotics Market Size 2021||USD 42 Billion|
|Antibiotics Market Forecast 2030||USD 63 Billion|
|Antibiotics Market CAGR During 2022 - 2030||4.6%|
|Antibiotics Market Analysis Period||2018 - 2030|
|Antibiotics Market Base Year||2021|
|Antibiotics Market Forecast Data||2022 - 2030|
|Segments Covered||By Product Type, By Drug Origin, By Spectrum, By Route of Administration, By Distribution Channel, And By Geography
|Regional Scope||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa|
|Key Companies Profiled||Abbott Laboratories, Allergan plc, Basilea Pharmaceutica Ltd., Bayer Healthcare AG, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Johnson & Johnson Inc., Melinta Therapeutics, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sanofi SA, and Tetraphase Pharmaceuticals.|
||Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis|
The development of advanced products by the major manufacturers along with the increasing infectious diseases burden is driving the market growth.
The increasing prevalence of infectious diseases such as lower respiratory infections, malaria, pneumonia, and tuberculosis are supporting the demand in the global market. The growing number of collaborations for the development of antibiotics among the major players is additionally bolstering the market value. The government and non-government bodies are increasing their investment budget in R&D initiatives and to boost the development of novel antibiotics and supportive regulatory policies due to increasing disease burden is further bolstering the market growth. Furthermore, the discovery of advanced prospect molecules, as well as the introduction of novel combination therapies to treat antibiotic-resistant microbial infections, is likely to create potential opportunities over the forecast period.
On the other side, high R&D cost and development of resistance against antibiotics are the factors likely to limit the growth to an extent during the estimated period.
Antibiotics Market Segmentation
The worldwide antibiotics market is split based on product type, drug origin, spectrum, route of administration, distribution channel, and geography.
Antibiotics Market By Product Type
Based on product type, the penicillin sub-segment achieved a significant share in 2021 and is expected to do so in the coming years from 2022 to 2030. The high growth in the segment is credited to the highest prescription and most number of generic manufacturers in the space.
Antibiotics Market By Drug Origin
According to our antibiotics industry analysis, the natural drug origin is anticipated to grow with a substantial rate from 2022 to 2030. On the other hand, synthetic and semi-synthetic are holding significant market share owing to easy availability.
Antibiotics Market By Spectrum
On the basis of spectrum, the broad-spectrum antibiotic is the leading segment in the global antibiotics market. These are active against a wider number of bacterial types and, thus have a demand for the treatment of a variety of infectious diseases. These are mostly used when the bacterial infection is suspected but the group of bacteria is unknown or in the case when infection with multiple groups of bacteria is suspected. The ability to treat a wider range of bacterial infections is primarily bolstering the segmental market value
Antibiotics Market By Route of Administration
In 2021, oral route of administration generated utmost market revenue and is expected to continue its trend during the forecast timeframe from 2022 to 2030. The easy availability and tremendous growth in oral prescription are some of the factors that are fueling the segmental growth.
Antibiotics Market By Distribution Channel
According to our antibiotics market forecast, retail pharmacy and hospital pharmacy are the major revenue generating segment in 2021. However, due to the trend of online shopping and increased e-commerce websites the online pharmacy sub-segment is likely to register the fastest growth rate from 2022 to 2030.
Antibiotics Market Regional Outlook
The Middle East & Africa (MEA)
Growth in Prevalence of Chronic Disorders Fuels the North America Antibiotics Market Share
Based on regions, North America leads the Antibiotics market. Growing healthcare sectors result in the adoption of diagnostic kits to detect various infectious diseases caused due to bacteria and viruses. On the other hand, Asia-Pacific is expected to witness the highest growth rate for the Antibiotics market owing to surging awareness among the healthcare sectors and ever-growing patient population about the rapid medical diagnostic tools.
Antibiotics Market Players
The global antibiotics companies profiled in the report include Abbott Laboratories, Allergan plc, Basilea Pharmaceutica Ltd., Bayer Healthcare AG, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Johnson & Johnson Inc., Melinta Therapeutics, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sanofi SA, and Tetraphase Pharmaceuticals.
What is the size of global antibiotics market in 2021?
The projected CAGR of antibiotics market during the analysis period of 2022 to 2030 is 4.6%.
The prominent players of the global antibiotics market are Abbott Laboratories, Allergan plc, Basilea Pharmaceutica Ltd., Bayer Healthcare AG, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Johnson & Johnson Inc., Melinta Therapeutics, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sanofi SA, and Tetraphase Pharmaceuticals.
Asia-Pacific held the dominating antibiotics during the analysis period of 2022 to 2030.
Asia-Pacific region exhibited fastest growing CAGR for antibiotics during the analysis period of 2022 to 2030.
Rising incidence of infectious diseases, increasing development of advanced products, and advent of novel approaches for new antibiotics drives the growth of global antibiotics market.
Based on product type, penicillin segment is expected to hold the maximum share antibiotics market.